1. Home
  2. Immunology and Biologics
  3. Comparative Safety and Efficacy

Comparative Safety and Efficacy

Rheumatoid Arthritis: Pathophysiology, Risk Factors and Guidelines Driven Management

Rheumatoid Arthritis: Pathophysiology, Risk Factors and Guidelines Driven Management

In the United States, the prevalence of rheumatoid arthritis (RA) has been…

Expiration Date: 9/1/2015

Max Credits: 0

View Activity

Safety Overview Looking at Differences and Similarities between Biologics

Safety Overview Looking at Differences and Similarities between Biologics

Dr. Ruderman will discuss safety issues with biological therapies…

Expiration Date: 8/12/2015

Max Credits: 0

View Activity

A Pan-European Registries Analysis of Abatacept Drug Retention in Rheumatoid Arthritis Patients with Inadequate Response to Prior Biologic Agents

A Pan-European Registries Analysis of Abatacept Drug Retention in Rheumatoid Arthritis Patients with Inadequate Response to Prior Biologic Agents

One of the projects that I'm presenting here at ACR is about Pan-European …

Expiration Date: 5/20/2015

Max Credits: 0

View Activity

Results from the Cererra Collaboration: Comparison of Fixed Versus On-flare Retreatment with Rituximab in RA

Results from the Cererra Collaboration: Comparison of Fixed Versus On-flare Retreatment with Rituximab in RA

Cererra Collaboration is a collaboration between 12 European countries wit…

Expiration Date: 5/20/2015

Max Credits: 0

View Activity